Merck HIV drug strategy may help protect patent, Bloomberg says Merck is poised to sell an HIV medication in India by mid-year in partnership with local company Cipla, a strategy that may allow the U.S. drug company to protect its patent as the Asian nation looks for less costly generics, according to Bloomberg, citing comments from Cipla's Chief Medical Officer. Reference Link
News For MRK From The Last 14 Days
Check below for free stories on MRK the last two weeks.
FDA approves Belsomra sleep drug The Food and Drug Administration approved Belsomra tablets for use as needed to treat difficulty in falling and staying asleep. Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information. Belsomra is a controlled substance because it can be abused or lead to dependence. Belsomra is made by Merck, Sharpe & Dohme.